Dove Medical Press

Dove Medical Press

Dove Medical Press is a publisher specializing in open access, peer-reviewed scientific and medical journals. It has offices located in Macclesfield and London in the UK, Princeton in the US, and Auckland in New Zealand. In September 2017, Dove Medical Press became part of the Taylor and Francis Group. As an open access publisher, Dove Medical Press requires a publication fee from authors, their institutions, or funding bodies. This fee helps cover the costs of editorial work and production, and it also contributes to a fund that provides fee waivers for authors from developing countries. The published articles can be accessed through an interface that complies with the Open Archives Initiative Protocol for Metadata Harvesting, which establishes consistent standards for managing archive metadata.

International
English
Journal

Outlet metrics

Domain Authority
80
Ranking

Global

#73334

United States

#62494

Health/Health

#1351

Traffic sources
Monthly visitors

Articles

  • 1 month ago | dovepress.com | Qin Wang |Lei Wang |Li Zhang |Chongyang Zhao

    Qin Wang,1,2,* Lei Wang,2,* Li Zhang,2 Chongyang Zhao,1 Ying Liu,2 Lei Liu,2 Lishan Yuan,2 Min Feng,3,4 Gang Wang,5 Li Li,1 Shuwen Zhang,6 Yulai Yuan,7 Deying Kang,1,8 Xin Zhang2 1Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic...

  • 1 month ago | dovepress.com | Xiaoqing Lin |Ziwei Zhang |TaoHu Zhou |Jie Li

    Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20 Authors Lin X, Zhang Z , Zhou T, Li J, Jin Q, Li Y, Guan Y , Xia Y, Zhou X, Fan L Received 26 November 2024 Accepted for publication 25 April 2025 Published 6 May 2025 Volume 2025:20 Pages 1395—1406 DOI https://doi.org/10.2147/COPD.S508775 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jill Ohar Xiaoqing Lin,1,2,*...

  • 2 months ago | dovepress.com

    Reporting the efficacy of aflibercept (8 mg) for diabetic macular edema (DME) in vitrectomized eyes refractory to other anti-VEGF drug therapies.

  • Mar 19, 2025 | dovepress.com | Roger Zaldivar |Roberto Zaldivar |Arthur B Cummings |Brendan Cummings

    Roger Zaldivar,1,* Roberto Zaldivar,1,* Arthur B Cummings,2,* Brendan K Cummings,2,* Erik LJG Mertens,3,* Robert Edward Ang,4,* Lucia Irupé Zarate Piscopo,1,5,* Gabriel Quintero,1,5,* Alejandro Cerviño6,* 1Department of Refractive & Cataract Surgery, Instituto Zaldivar, Mendoza, Argentina; 2Department of Cataract & Refractive Surgery, Wellington Eye Clinic, Dublin, Ireland; 3Department of Ophthalmology, Medipolis Medical Research Institute, Antwerp,...

  • Mar 17, 2025 | dovepress.com | Preeya K. Gupta |Vance Thompson |Leslie O’dell |Anh Ho

    Preeya K Gupta,1 Vance Thompson,2 Leslie O’Dell,2 Anh N Ho,3 Arthur Chan,3 Bhagyashree Oak,4 Amod Athavale,4 Elizabeth Yeu3 1Triangle Eye Consultants, Raleigh, NC, USA; 2Vance Thompson Vision, Sioux Falls, SD, USA; 3Tarsus Pharmaceuticals, Inc, Irvine, CA, USA; 4Trinity Life Sciences, Waltham, MA, USA Correspondence: Amod Athavale, Trinity Life Sciences, 230 3rd Ave, Waltham, MA, 02451, USA, Email [email protected] Background: Demodex blepharitis is an ocular disorder caused by the...